StageSeed VC | Alive
Last Raised$1.14M | 4 yrs ago
Sancare has developed a software that uses machine learning to recognize the pathologies described in a patient file and to deduce the performed hospital acts. This relieves doctors of tedious administrative work and allows hospitals to charge more accurately their activity to the Health Insurance.
Missing: Sancare's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Sancare's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Research containing Sancare
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Sancare in 1 CB Insights research brief, most recently on Oct 10, 2022.
Expert Collections containing Sancare
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Sancare is included in 4 Expert Collections, including Artificial Intelligence.
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Health Plans & Benefits Management
Companies developing or offering digital platforms and services, including online insurance marketplaces, data analytics for claims adjustment, benefits administration, and payments systems, that help make private health insurance more affordable, navigable, or transparent.
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Latest Sancare News
Aug 14, 2019
Sancare , artificial intelligence software for healthcare facilities announces € 1 million in funding from Elaia Partners (PSL Innovation Fund), Davidson Group and business angels such as Franck Le Ouay and Romain Niccoli. Founded in 2016 by Thomas Duval, Fajwel Fogel and Franck Charras, Sancare enables hospitals to better treat their patients at a lower cost through artificial intelligence. While significant financial efforts are required from public and private health facilities, they face significant administrative costs related to the billing of hospital stays and non-exhaustiveness of the coding (transcription of the patient file into a code that triggers a billing to health insurance). Sancare provides healthcare facilities with the tools to predict billing codes from the patient’s Electronic Health record using NLP (Natural Language Processing) technology. French hospitals represent a total market of 70 billion euros (both public and private). Sancare aims at saving up to 0.5% of health care facilities through automation and increased hospital revenue by reducing the billing oversights. Sancare already works with twenty major players in both the private and the public sectors such as the AHNAC group (Nord Artois Clinical Hospital Association) and the Curie Institute. The co-founders have a rare combination of both business and technical skills: Thomas Duval has been a consultant at McKinsey for 10 years mainly in the health sector, Faiwel Fogel obtained a doctorate in Machine Learning after conducting research at ENS and Ecole Polytechnique and Franck Charras has a master in machine learning from ENS Paris-Saclay. They are followed by a high-level scientific council, especially research teams from PSL University (Curie, ENS, INRIA, MINES ParisTech) and wish to develop even more links with PSL University in the future. Thomas Duval, CEO of Sancare, is delighted: ”Sancare is one of the very first practical application of Artificial Intelligence that makes it possible to valorize the data of big health centers by bringing them an immediate ROI. This fundraising will allow us to accelerate the development, both technical and commercial, of the solution as well as to strengthen the team, especially at the R & D level “. Anne-Sophie Carrese, Partner at Elaia declares: ”Sancare is a great Artificial Intelligence company resulting from the academic excellence of PSL University with a management team that is both highly qualified from a technical point of view and highly connected to business. This team has been able to convince leading healthcare and medical data clients. This second investment by the PSL Innovation Fund, in a promising tech startup, confirms the depth and quality of PSL’s deal flow.” Bertrand Bailly, CEO of Davidson says: ”What convinced us is both the vision of the company that aims to develop a range of solutions based on Artificial Intelligence, to provide real added value to hospitals and clinics, as well as the the quality of the management team that has both high-level skills in Machine Learning and a good knowledge of the health world. “
Sancare Frequently Asked Questions (FAQ)
When was Sancare founded?
Sancare was founded in 2016.
Where is Sancare's headquarters?
Sancare's headquarters is located at 3 Rue de la Petite Pierre, Paris.
What is Sancare's latest funding round?
Sancare's latest funding round is Seed VC.
How much did Sancare raise?
Sancare raised a total of $1.14M.
Who are the investors of Sancare?
Investors of Sancare include Elaia Partners, Davidson Consulting, Romain Niccoli and Franck le Ouay.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.